ATE365536T1 - Lösungsmittelsysteme für pharmazeutische mittel - Google Patents

Lösungsmittelsysteme für pharmazeutische mittel

Info

Publication number
ATE365536T1
ATE365536T1 AT01998324T AT01998324T ATE365536T1 AT E365536 T1 ATE365536 T1 AT E365536T1 AT 01998324 T AT01998324 T AT 01998324T AT 01998324 T AT01998324 T AT 01998324T AT E365536 T1 ATE365536 T1 AT E365536T1
Authority
AT
Austria
Prior art keywords
phase
solvent systems
pharmaceutical products
solvent
solubilize
Prior art date
Application number
AT01998324T
Other languages
English (en)
Inventor
David Anderson
Original Assignee
Lyotropic Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lyotropic Therapeutics Inc filed Critical Lyotropic Therapeutics Inc
Application granted granted Critical
Publication of ATE365536T1 publication Critical patent/ATE365536T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant
    • A61K9/1274—Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases or cochleates; Sponge phases
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/107—Emulsions ; Emulsion preconcentrates; Micelles
    • A61K9/1075—Microemulsions or submicron emulsions; Preconcentrates or solids thereof; Micelles, e.g. made of phospholipids or block copolymers

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Dispersion Chemistry (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Steroid Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AT01998324T 2000-11-29 2001-11-28 Lösungsmittelsysteme für pharmazeutische mittel ATE365536T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US25387400P 2000-11-29 2000-11-29

Publications (1)

Publication Number Publication Date
ATE365536T1 true ATE365536T1 (de) 2007-07-15

Family

ID=22962053

Family Applications (1)

Application Number Title Priority Date Filing Date
AT01998324T ATE365536T1 (de) 2000-11-29 2001-11-28 Lösungsmittelsysteme für pharmazeutische mittel

Country Status (9)

Country Link
US (1) US20020102280A1 (de)
EP (1) EP1345589B1 (de)
JP (1) JP2004514690A (de)
AT (1) ATE365536T1 (de)
AU (1) AU1987802A (de)
CA (1) CA2428993C (de)
DE (1) DE60129156T2 (de)
ES (1) ES2289015T3 (de)
WO (1) WO2002043696A1 (de)

Families Citing this family (38)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20030045587A1 (en) * 2001-06-23 2003-03-06 David Anderson Solvent system
US7758890B2 (en) 2001-06-23 2010-07-20 Lyotropic Therapeutics, Inc. Treatment using dantrolene
DE10141650C1 (de) 2001-08-24 2002-11-28 Lohmann Therapie Syst Lts Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen
US7588786B2 (en) * 2001-11-14 2009-09-15 Jarrow Formulas, Inc. Eutectic-based self-nanoemulsified drug delivery system
EP1539099A4 (de) * 2002-06-13 2009-03-18 Lyotropic Therapeutics Llc Umgekehrte flüssigkristalline phasen mit nichtparaffinischen hydrophoben
IL158509A (en) * 2003-10-20 2010-11-30 Biomor Israel Ltd Non-phytotoxic biocide composition containing tea tree oil and method for production thereof
US20100297252A1 (en) * 2003-03-03 2010-11-25 Elan Pharma International Ltd. Nanoparticulate meloxicam formulations
CA2516667C (en) 2003-03-04 2012-05-29 Lyotropic Therapeutics, Inc. Treatment using dantrolene
PE20050386A1 (es) * 2003-05-29 2005-06-23 Schering Plough Ltd Composiciones farmaceuticas de florfenicol
ITMI20032019A1 (it) * 2003-10-17 2005-04-18 Fidia Farmaceutici Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
US20050260152A1 (en) * 2004-05-03 2005-11-24 Jaghab Khalil C Hair growth composition
EP1598060A1 (de) 2004-05-18 2005-11-23 Nestec S.A. Öl-in-Wasser-Emulsion für Lieferung
US9700704B2 (en) 2006-11-20 2017-07-11 Lutonix, Inc. Drug releasing coatings for balloon catheters
US8414909B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8414526B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
US8425459B2 (en) 2006-11-20 2013-04-23 Lutonix, Inc. Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
US9737640B2 (en) 2006-11-20 2017-08-22 Lutonix, Inc. Drug releasing coatings for medical devices
US8414910B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
US8998846B2 (en) 2006-11-20 2015-04-07 Lutonix, Inc. Drug releasing coatings for balloon catheters
US20080276935A1 (en) 2006-11-20 2008-11-13 Lixiao Wang Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
US8414525B2 (en) 2006-11-20 2013-04-09 Lutonix, Inc. Drug releasing coatings for medical devices
EP2102154A1 (de) * 2006-12-13 2009-09-23 Schering-Plough Ltd. Wasserlösliche chloramphenicol- und thiamphenicol-prodrugs sowie analoga davon
JP5515075B2 (ja) * 2007-01-18 2014-06-11 国立大学法人 千葉大学 微粒子製剤
CA2686225A1 (en) * 2007-06-22 2008-12-31 Scidose Llc Solubilized formulation of docetaxel without tween 80
GB0716385D0 (en) * 2007-08-22 2007-10-03 Camurus Ab Formulations
US9180088B2 (en) 2008-03-07 2015-11-10 Scidose, Llc Fulvestrant formulations
WO2010024898A2 (en) 2008-08-29 2010-03-04 Lutonix, Inc. Methods and apparatuses for coating balloon catheters
US8912228B2 (en) 2009-10-19 2014-12-16 Scidose Llc Docetaxel formulations with lipoic acid
US7772274B1 (en) 2009-10-19 2010-08-10 Scidose, Llc Docetaxel formulations with lipoic acid
US8541465B2 (en) * 2009-10-19 2013-09-24 Scidose, Llc Docetaxel formulations with lipoic acid and/or dihydrolipoic acid
US20110092579A1 (en) * 2009-10-19 2011-04-21 Scidose Llc Solubilized formulation of docetaxel
SG185389A1 (en) 2010-05-03 2012-12-28 Teikoku Pharma Usa Inc Non-aqueous taxane pro-emulsion formulations and methods of making and using the same
US11179468B2 (en) 2012-04-09 2021-11-23 Eagle Pharmaceuticals, Inc. Fulvestrant formulations
JO3685B1 (ar) 2012-10-01 2020-08-27 Teikoku Pharma Usa Inc صيغ التشتيت الجسيمي للتاكسين غير المائي وطرق استخدامها
US9669012B2 (en) 2014-10-30 2017-06-06 Textile-Based Delivery, Inc. Delivery systems
KR102728201B1 (ko) 2016-11-02 2024-11-08 트러스티즈 오브 터프츠 칼리지 여과 멤브레인의 제조
CA2981394A1 (en) * 2017-09-28 2019-03-28 Chuck Chang Curcuminoid compositions and preparation methods
CN116850159B (zh) * 2023-07-12 2025-08-22 浙江同伍生物医药有限公司 一种盐酸左沙丁胺醇雾化吸入溶液组合物及其制备方法

Family Cites Families (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS5791927A (en) * 1980-11-27 1982-06-08 Nippon Mejifuijitsukusu Kk Technetium-99m labelled diagnosticum
SE8206744D0 (sv) * 1982-11-26 1982-11-26 Fluidcarbon International Ab Preparat for kontrollerad avgivning av substanser
US5026548A (en) * 1987-04-28 1991-06-25 Cadbury Schweppes Plc Surfactant
US5223264A (en) * 1989-10-02 1993-06-29 Cima Labs, Inc. Pediatric effervescent dosage form
EP0643620B1 (de) * 1991-10-04 1999-07-21 Gs Development Ab Teilchen, methode zur herstellung der teilchen und deren verwendung
US5541287A (en) * 1992-06-09 1996-07-30 Neorx Corporation Pretargeting methods and compounds
US5569218A (en) * 1994-02-14 1996-10-29 Scimed Life Systems, Inc. Elastic guide catheter transition element
US5618522A (en) * 1995-01-20 1997-04-08 The Procter & Gamble Company Emulsion compositions
US5681846A (en) * 1995-03-17 1997-10-28 Board Of Regents, The University Of Texas System Extended stability formulations for paclitaxel
CA2224227A1 (en) * 1995-06-07 1996-12-19 Avmax, Inc. Use of essential oils to increase bioavailability of oral pharmaceutical compounds
JPH09124503A (ja) * 1995-10-27 1997-05-13 L T T Kenkyusho:Kk アミチアマイシン類の注射用の抗菌性組成物
US5891465A (en) * 1996-05-14 1999-04-06 Biozone Laboratories, Inc. Delivery of biologically active material in a liposomal formulation for administration into the mouth
US6458373B1 (en) * 1997-01-07 2002-10-01 Sonus Pharmaceuticals, Inc. Emulsion vehicle for poorly soluble drugs
US6090800A (en) * 1997-05-06 2000-07-18 Imarx Pharmaceutical Corp. Lipid soluble steroid prodrugs
DE69837903T2 (de) * 1997-08-11 2008-02-14 Pfizer Products Inc., Groton Feste pharmazeutische Dispersionen mit erhöhter Bioverfügbarkeit
AU747252B2 (en) * 1997-09-09 2002-05-09 Lyotropic Therapeutics, Inc. Coated particles, methods of making and using

Also Published As

Publication number Publication date
EP1345589A4 (de) 2004-01-28
AU1987802A (en) 2002-06-11
EP1345589A1 (de) 2003-09-24
EP1345589B1 (de) 2007-06-27
DE60129156D1 (de) 2007-08-09
CA2428993C (en) 2011-05-31
US20020102280A1 (en) 2002-08-01
DE60129156T2 (de) 2008-03-13
JP2004514690A (ja) 2004-05-20
CA2428993A1 (en) 2002-06-06
ES2289015T3 (es) 2008-02-01
WO2002043696A1 (en) 2002-06-06

Similar Documents

Publication Publication Date Title
ATE365536T1 (de) Lösungsmittelsysteme für pharmazeutische mittel
HUP0400263A2 (hu) Koleszteril-észter transzfer protein inhibitort tartalmazó önemulgeáló készítmény
ATE415943T1 (de) Pharmazeutische zubereitungen enthaltend einen amphoteren emulgator, polyproxylierten cetylalkohol und einen polaren wirkstoff
IT1291362B1 (it) Composizioni farmaceutiche multicomponente bifasiche contenenti sostanze atte a modificare la partizione dei principi attivi
ATE399847T1 (de) Reinigungsmittel vom typ der multiplen emulsion
PL365874A1 (pl) Dyspersje do wytwarzania słabo lub trudno rozpuszczalnych składników aktywnych
BR0000126A (pt) Adjuvantes para uso em vacinas
Radomska et al. The use of some ingredients for microemulsion preparation containing retinol and its esters
CY1109135T1 (el) Φαρμακευτικο διαλυμα το οποιο περιλαμβανει ριτοναβιρη, εναν διαλυτη (μακριας αλυσιδας λιπαρο οξυ) και νερο
EE200200483A (et) Uus iseemulgeeruv ravimi manustamise süsteem
JP2004514690A5 (de)
ES2177503T3 (es) Composicion en forma de una emulsion de agua-en-aceite que contiene fibras, y la utilizacion de dicha composicion.
ATE359779T1 (de) Selbstemulgierende systeme zur abgabe von taxoiden
BR0111047B1 (pt) microemulsço de fase énica; e, sua utilizaÇço.
MX376179B (es) Composicion de gel vibrante.
EP1349545A4 (de) Pharmazeutische zusammensetzungen von fenretinid mit erhöhter bioverfügbarkeit und verfahren zu deren verwendung
ATE516016T1 (de) Selbstemulgierende formulierungen von cetp- hemmern
BR0114969A (pt) Formulações de emulsificação própria de dosagem oral de inibidores de piranona protease
ITMI20032019A1 (it) Microemulsioni di retinoidi e composizioni farmaceutiche che le contengono
BRPI0411899A (pt) sistema tensoativo para uso em um fluido lipofìlico
DZ3459A1 (fr) Derives de 2h-1-benzopyran, procedes de preparation de ces derniers et compositions pharmaceutiques dans lesquels ils entrent.
BRPI0513051A (pt) combinação de inibidores de transcriptase reversa e de protease anti-hiv
ATE208190T1 (de) Pharmazeutische emulsionen, die bioaktive steroide enthalten
WO2006039268A3 (en) Pharmaceutical formulations containing vitamin e tpgs molecules that solubilize lipophilic drugs without significant efflux inhibition, and use of such formulations
PT1165091E (pt) Emulsoes farmaceuticas para inibidores de protease retroviral

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1345589

Country of ref document: EP

REN Ceased due to non-payment of the annual fee